Update on dopa-responsive dystonia: locus heterogeneity and biochemical features

Adv Neurol. 2004:94:127-38.

Author

Yoshiaki Furukawa¹

Affiliation

¹ Movement Disorders Research Laboratory, Centre for Addiction and Mental Health-Clarke Division, Toronto, Ontario, Canada.

PMID: 14509665

No abstract available

Publication types

Review

MeSH terms

Antiparkinson Agents / therapeutic use
Brain Chemistry*
Dystonia / classification
Dystonia / complications
Dystonia / drug therapy
Dystonia / genetics*
Family Health
GTP Cyclohydrolase / deficiency
GTP Cyclohydrolase / genetics*
Genetic Heterogeneity*
Genetic Linkage
Humans
Levodopa / therapeutic use
Motor Activity
Mutation
Parkinson Disease, Secondary / complications
Parkinson Disease, Secondary / genetics
Phenylketonurias / etiology
Phenylketonurias / genetics
Tyrosine 3-Monooxygenase / genetics*

Substances

Antiparkinson Agents
Levodopa
Tyrosine 3-Monooxygenase
GTP Cyclohydrolase